Therapeutic delivery of RNA effectors: diseases affecting the respiratory system
Although there are several hurdles to overcome on the way to the lung, this target organ provides several advantages for successful drug absorption. Recent findings in this field of research give reason to assume that the pulmonary delivery of RNA effector molecules holds a promising potential for the treatment of numerous severe respiratory diseases.
No Supplementary Data.
No Article Media
Document Type: Review Article
Publication date: January 1, 2016
More about this publication?
- Pharmazie is a leading journal in the field of pharmaceutical sciences. As a peer-reviewed scientific journal, Pharmazie is regularly indexed in the relevant databases like Web of science, Journal Citation Reports and many others. The journal is open for submissions from the whole spectrum of pharnaceutical sciences including Pharmaceutical Chemistry, Experimental and Clinical Pharmacology, Drug Analysis, Pharmaceutics, Pharmaceutical Biology, Clinical Pharmacy etc.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites